Literature DB >> 8670039

The prognosis of oral mucosal squamous cell carcinomas: a comparison of clinical and histopathological grading and of laminin and type IV collagen staining.

N A Firth1, P C Reade.   

Abstract

Changes in the distribution of basement membrane components have been described in dysplastic lesions and in oral mucosal squamous cell carcinomas (OMSCC). The purpose of this study was to determine if these changes were related to pathological grade and if so, whether this had prognostic implications. Fifty formalin-fixed, paraffin-embedded specimens of OMSCC, with five or more years clinical follow-up, were studied using an immunoperoxidase technique for the detection of the basement membrane components, laminin and type IV collagen. The immunoreactivity of each component was evaluated and semiquantitatively scored as minimal, moderate or extensive and the results compared with the tumour size, node involvement and metastasis (TNM) clinical staging system and histopathological features. OMSCC were characterized by minimal or moderate staining with small islands of neoplastic cells frequently lacking staining for laminin and type IV collagen. Deposition of these components decreased with increased histopathological grade and absence of staining was more commonly associated with a poor prognosis. In particular the pattern of type IV collagen staining frequently differed from laminin staining. Neither of these parameters offered an advantage over TNM clinical staging with regard to prognosis. It was concluded that variations in laminin and type IV collagen immunoreactivity occurred in OMSCC and that high histopathological grade tumours with considerably diminished staining with anti-laminin and anti-type IV collagen carried a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670039     DOI: 10.1111/j.1834-7819.1996.tb05918.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  7 in total

1.  Non-invasive detection of nasopharyngeal carcinoma using saliva surface-enhanced Raman spectroscopy.

Authors:  Sufang Qiu; Yuanji Xu; Lingling Huang; Wei Zheng; Chaobin Huang; Shaohua Huang; Jinyong Lin; Duo Lin; Shangyuan Feng; Rong Chen; Jianji Pan
Journal:  Oncol Lett       Date:  2015-11-24       Impact factor: 2.967

2.  Differential expression of basement membrane collagen-IV alpha1 to alpha6 chains during oral carcinogenesis.

Authors:  Ryo Tamamura; Hitoshi Nagatsuka; Chong Huat Siar; Naoki Katase; Ichiro Naito; Yoshikazu Sado; Noriyuki Nagai
Journal:  Virchows Arch       Date:  2006-08-16       Impact factor: 4.064

Review 3.  The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.

Authors:  Sara Hadjigol; Bansari A Shah; Neil M O'Brien-Simpson
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 4.  Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.

Authors:  Sabah Nisar; Parvaiz Yousuf; Tariq Masoodi; Nissar A Wani; Sheema Hashem; Mayank Singh; Geetanjali Sageena; Deepika Mishra; Rakesh Kumar; Mohammad Haris; Ajaz A Bhat; Muzafar A Macha
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

5.  Immunohistochemical expression of basement membrane laminin in histological grades of oral squamous cell carcinoma: A semiquantitative analysis.

Authors:  R Shruthy; P Sharada; Uma Swaminathan; Br Nagamalini
Journal:  J Oral Maxillofac Pathol       Date:  2013-05

6.  Immunohistochemical Analysis of Collagen IV and Laminin Expression in Spontaneous Melanoma Regression in the Melanoma-Bearing Libechov Minipig.

Authors:  Daniela Planska; Monika Burocziova; Jan Strnadel; Vratislav Horak
Journal:  Acta Histochem Cytochem       Date:  2015-02-24       Impact factor: 1.938

7.  Expression of basement membrane laminin in oral squamous cell carcinomas.

Authors:  Silvia Regina de Almeida Reis; Leonardo Francisco Provedel de Souza; Verônica Ferreira de Souza; Lílian Dantas de Góes Silva; Jean Nunes Dos Santos
Journal:  Braz J Otorhinolaryngol       Date:  2007 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.